These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 19934646)

  • 1. Frequent epigenetic inactivation of RASSF10 in thyroid cancer.
    Schagdarsurengin U; Richter AM; Wöhler C; Dammann RH
    Epigenetics; 2009 Nov; 4(8):571-6. PubMed ID: 19934646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RASSF10 promoter hypermethylation is frequent in malignant melanoma of the skin but uncommon in nevus cell nevi.
    Helmbold P; Richter AM; Walesch S; Skorokhod A; Marsch WCh; Enk A; Dammann RH
    J Invest Dermatol; 2012 Mar; 132(3 Pt 1):687-94. PubMed ID: 22113481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequent epigenetic inactivation of RASSF2 in thyroid cancer and functional consequences.
    Schagdarsurengin U; Richter AM; Hornung J; Lange C; Steinmann K; Dammann RH
    Mol Cancer; 2010 Sep; 9():264. PubMed ID: 20920251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequent epigenetic silencing of the CpG island promoter of RASSF1A in thyroid carcinoma.
    Schagdarsurengin U; Gimm O; Hoang-Vu C; Dralle H; Pfeifer GP; Dammann R
    Cancer Res; 2002 Jul; 62(13):3698-701. PubMed ID: 12097277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RASSF10 is Epigenetically Inactivated and Suppresses Cell Proliferation and Induces Cell Apoptosis by Activating the p53 Signalling Pathway in Papillary Thyroid Carcinoma Cancer.
    Fan C; Wang W; Jin J; Yu Z; Xin X
    Cell Physiol Biochem; 2017; 41(3):1229-1239. PubMed ID: 28268222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The novel RASSF6 and RASSF10 candidate tumour suppressor genes are frequently epigenetically inactivated in childhood leukaemias.
    Hesson LB; Dunwell TL; Cooper WN; Catchpoole D; Brini AT; Chiaramonte R; Griffiths M; Chalmers AD; Maher ER; Latif F
    Mol Cancer; 2009 Jul; 8():42. PubMed ID: 19570220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RASSF10 is an epigenetically silenced tumor suppressor in gastric cancer.
    Li Z; Chang X; Dai D; Deng P; Sun Q
    Oncol Rep; 2014 Apr; 31(4):1661-8. PubMed ID: 24573726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RASSF10 is epigenetically inactivated and induces apoptosis in lung cancer cell lines.
    Wang Y; Ma T; Bi J; Song B; Zhou Y; Zhang C; Gao M
    Biomed Pharmacother; 2014 Apr; 68(3):321-6. PubMed ID: 24433832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RASSF10 is frequently epigenetically inactivated in kidney cancer and its knockout promotes neoplasia in cancer prone mice.
    Richter AM; Woods ML; Küster MM; Walesch SK; Braun T; Boettger T; Dammann RH
    Oncogene; 2020 Apr; 39(15):3114-3127. PubMed ID: 32047266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RASSF10 is epigenetically silenced and functions as a tumor suppressor in gastric cancer.
    Wei Z; Chen X; Chen J; Wang W; Xu X; Cai Q
    Biochem Biophys Res Commun; 2013 Mar; 432(4):632-7. PubMed ID: 23428420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic down regulation of RASSF10 and its possible clinical implication in prostate carcinoma.
    Dansranjavin T; Wagenlehner F; Gattenloehner S; Steger K; Weidner W; Dammann R; Schagdarsurengin U
    Prostate; 2012 Oct; 72(14):1550-8. PubMed ID: 22415519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RASSF10 is an epigenetically inactivated tumor suppressor and independent prognostic factor in hepatocellular carcinoma.
    Wang F; Feng Y; Li P; Wang K; Feng L; Liu YF; Huang H; Guo YB; Mao QS; Xue WJ
    Oncotarget; 2016 Jan; 7(4):4279-97. PubMed ID: 26701853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ras association domain family member 10 suppresses gastric cancer growth by cooperating with GSTP1 to regulate JNK/c-Jun/AP-1 pathway.
    Li X; Liang Q; Liu W; Zhang N; Xu L; Zhang X; Zhang J; Sung JJ; Yu J
    Oncogene; 2016 May; 35(19):2453-64. PubMed ID: 26279301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequent silencing of RASSF1A via promoter methylation in follicular thyroid hyperplasia: a potential early epigenetic susceptibility event in thyroid carcinogenesis.
    Brown TC; Juhlin CC; Healy JM; Prasad ML; Korah R; Carling T
    JAMA Surg; 2014 Nov; 149(11):1146-52. PubMed ID: 25229773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The tumor suppressor RASSF10 is upregulated upon contact inhibition and frequently epigenetically silenced in cancer.
    Richter AM; Walesch SK; Würl P; Taubert H; Dammann RH
    Oncogenesis; 2012 Jun; 1(6):e18. PubMed ID: 23552700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetic inactivation of the RASSF10 candidate tumor suppressor gene is a frequent and an early event in gliomagenesis.
    Hill VK; Underhill-Day N; Krex D; Robel K; Sangan CB; Summersgill HR; Morris M; Gentle D; Chalmers AD; Maher ER; Latif F
    Oncogene; 2011 Feb; 30(8):978-89. PubMed ID: 20956940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic silencing of RASSF10 promotes tumor growth in esophageal squamous cell carcinoma.
    Lu D; Ma J; Zhan Q; Li Y; Qin J; Guo M
    Discov Med; 2014 Apr; 17(94):169-78. PubMed ID: 24759621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The RASSF gene family members RASSF5, RASSF6 and RASSF7 show frequent DNA methylation in neuroblastoma.
    Djos A; Martinsson T; Kogner P; Carén H
    Mol Cancer; 2012 Jun; 11():40. PubMed ID: 22695170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aberrant Promoter Methylation of the Tumour Suppressor RASSF10 and Its Growth Inhibitory Function in Breast Cancer.
    Richter AM; Walesch SK; Dammann RH
    Cancers (Basel); 2016 Feb; 8(3):. PubMed ID: 26927176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcriptional regulation of the potential tumor suppressor ABI3 gene in thyroid carcinomas: interplay between methylation and NKX2-1 availability.
    Moraes L; Galrão AL; Rubió I; Cerutti JM
    Oncotarget; 2016 May; 7(18):25960-70. PubMed ID: 27036019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.